The present invention relates to substituted diphenyl heterocycle
compounds and pharmaceutical compositions thereof that inhibit
replication of HCV virus. The present invention also relates to the use
of the compounds and/or compositions to inhibit HCV replication and/or
proliferation and to treat or prevent HCV infections.